Target intelligence / Profile preview

Pathogenic gastrointestinal microorganism

Molecular classification
Other (not a single molecule; includes bacteria, viruses, and parasites), Bacteria (e.g., Salmonella spp., Shigella spp., Escherichia coli pathotypes), Viruses (e.g., Norovirus, Rotavirus), Parasites (e.g., Giardia lamblia)
01

Overview

"Pathogenic gastrointestinal microorganism" refers collectively to any microbe—primarily certain species of bacteria (*Salmonella*, *Shigella*, *Escherichia coli* pathotypes), viruses (Norovirus), and parasites—that can cause infectious diseases within the human digestive tract. These organisms may invade intestinal cells directly or produce toxins that disrupt normal gut function. Clinical manifestations range from mild self-limited diarrhea to life-threatening systemic illness depending on both pathogen type and host factors. Because this term encompasses many unrelated biological entities rather than one defined molecular structure or receptor, it does not fit standard definitions used for therapeutic targets such as receptors or enzymes[1][3][4].

Other names
Gastrointestinal pathogensEnteric pathogensGI pathogensIntestinal pathogenic microorganisms
02

Mechanism of action

Varies by pathogen and drug: Antibiotics inhibit cell wall synthesis or protein synthesis in bacteria. Antiparasitics disrupt protozoal metabolism. Supportive care addresses dehydration rather than directly targeting the organism.

03

Biological functions

Infection and colonization of the gastrointestinal tractToxin production leading to diarrhea and other symptomsEvasion of host immune response
04

Disease associations

Infection (gastroenteritis)Foodborne illnessDiarrheal diseasesInflammatory complications in susceptible hosts
05

Safety considerations

Antibiotic resistance among enteric bacteriaDisruption of normal gut microbiota with broad-spectrum antibiotics can lead to secondary infections like Clostridioides difficile colitis.Some populations are at higher risk for severe disease (infants, elderly, immunocompromised).
06

Interacting drugs

Antibiotics for bacterial infections (e.g., ciprofloxacin for Salmonella/Shigella; metronidazole for Giardia)

2 more in the full profile.

07

Biomarkers

Detection of pathogen-specific antigens/toxins in stool samplesPCR-based identification of microbial DNA/RNA

Beyond the preview

Go deeper on Pathogenic gastrointestinal microorganism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic gastrointestinal microorganism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call